Brands: Tivicay · Dolutegravir Sodium
Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| ViiV Healthcare Company | unknown | 3 | SUPPLYING |
| St. Mary's Medical Park Pharmacy | repackager | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Labeling: Incorrect Lot and/or Expiration Date: The carton has incorrect expiration of 2026-MAY*, whereas the correct expiration date, which is on the tablet bottle label, is 2025-APR. — Recalling firm: GlaxoSmithKline LLC — Nationwide within the United States
Labeling: incorrect or missing lot and/or expiration date. An incorrect expiration date was printed on the product labeling with an expiration date of January 2027, whereas the correct expiration date is September 2026. — Recalling firm: GlaxoSmithKline LLC — Nationwide in the U.S.
Cross Contamination with Other Products: Product contains Promacta (eltrombopag). — Recalling firm: Viiv Healthcare Company — Nationwide including Puerto Rico
